CRID3, a blocker of apoptosis associated speck like protein containing a card, ameliorates murine spinal cord injury by improving local immune microenvironment

• Published in: Journal of neuroinflammation 2020-08, Vol.17 (1), p.1-255, Article 255
• Main Authors: Chen, Yu-Qing, Wang, Sai-Nan, Shi, Yu-Jiao, Chen, Jing, Ding, Shu-Qin, Tang, Jie, Shen, Lin, Wang, Rui, Ding, Hai, Hu, Jian-Guo, Lü, He-Zuo
• Format: Article
• Language: English
• Subjects: Antibodies; Apoptosis; Apoptosis-associated speck-like protein containing a card; Caspase-1; Cellular proteins; Complications and side effects; CRID3; Fibrosis; Flow cytometry; Genetic aspects; Health aspects; Humidity; IL-1β; Immune microenvironment; Inflammasome; Inflammasomes; Inflammation; Interleukin 18; Laboratory animals; Locomotor recovery; Lymphocytes T; Microglia; Myelin; Neurologic manifestations; Neuroprotection; Oligomerization; Pattern recognition; Preservation; Proteins; Recovery of function; Risk factors; Signal transduction; Spinal cord injuries; Spinal cord injury; Surgery; Vertebrae
• ISSN: 1742-2094; 1742-2094
• DOI: 10.1186/s12974-020-01937-8

Background After spinal cord injury (SCI), destructive immune cell subsets are dominant in the local microenvironment, which are the important mechanism of injury. Studies have shown that inflammasomes play an important role in the inflammation following SCI, and apoptosis-associated speck-like protein containing a card (ASC) is the adaptor protein shared by inflammasomes. Therefore, we speculated that inhibiting ASC may improve the local microenvironment of injured spinal cord. Here, CRID3, a blocker of ASC oligomerization, was used to study its effect on the local microenvironment and the possible role in neuroprotection following SCI. Methods Murine SCI model was created using an Infinite Horizon impactor at T9 vertebral level with a force of 50 kdynes and CRID3 (50 mg/kg) was intraperitoneally injected following injury. ASC and its downstream molecules in inflammasome signaling pathway were measured by western blot. The immune cell subsets were detected by immunohistofluorescence (IHF) and flow cytometry (FCM). The spinal cord fibrosis area, neuron survival, myelin preservation, and functional recovery were assessed. Results Following SCI, CRID3 administration inhibited inflammasome-related ASC and caspase-1, IL-1[beta], and IL-18 activation, which consequently suppressed M1 microglia, Th1 and Th1Th17 differentiation, and increased M2 microglia and Th2 differentiation. Accordingly, the improved histology and behavior have also been found. Conclusions CRID3 may ameliorate murine SCI by inhibiting inflammasome activation, reducing proinflammatory factor production, restoring immune cell subset balance, and improving local immune microenvironment, and early administration may be a promising therapeutic strategy for SCI. Keywords: Spinal cord injury, CRID3, Inflammasome, Apoptosis-associated speck-like protein containing a card, Immune microenvironment, Locomotor recovery